Nivolumab vs Omega-3-Acid Ethyl Esters
Nivolumab vs Omega-3-Acid Ethyl Esters: Overview
This comparison examines the pharmacological differences between Nivolumab and Omega-3-Acid Ethyl Esters.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Nivolumab β 27 days.
Chemical Properties
Type: Nivolumab β Antibody; Omega-3-Acid Ethyl Esters β Small molecule.